相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
1358099-18-9
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥1611.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥685.0 |
| 规格: | 5 mg | 产品价格: | ¥1600.0 |
| 规格: | 10 mg | 产品价格: | ¥2600.0 |
| 规格: | 25 mg | 产品价格: | ¥4538.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
C25-140
CAS No. : 1358099-18-9
MCE 国际站:C25-140
产品活性:C25-140 是一种首创的,具有口服活性和一定选择性的 TRAF6-Ubc13 相互作用的抑制剂,直接与 TRAF6 结合,阻断 TRAF6 和 Ubc13 的相互作用,从而降低 TRAF6 活性,降低 NF-κB 的活性,并对抗自身免疫。
研究领域:Apoptosis | Metabolic Enzyme/Protease
作用靶点:TNF Receptor | E1/E2/E3 Enzyme
In Vitro: C25-140 dose-dependently impedes TRAF6-Ubc13 interaction.
?C25-140 (10-30 μM; 2 hours) effectively reduces TRAF6-mediated ubiquitin chain formation.
?C25-140 affects TNFα-induced phosphorylation of IκBα as well as NF-κB-induced target gene expression.
?C25-140 efficiently inhibits IL-1β- and TNFα-mediated receptor signaling in the context of cytokine activation.
In Vivo: C25-140 (~1.5 mg/kg; topically to the shaved back and the right ear; twice daily for 6 days) ameliorates symptoms of autoimmune psoriasis in R 837-induced psoriasis mouse model.
?C25-140 (6-14 mg/kg; given i.p.; twice daily for 14 days) shows a dose-dependent improvement of RA disease outcome in Collagen-induced arthritis (CIA) model.
?C25-140 (10 mg/kg; i.v.) treatment shows that the Cmax, AUC, t1/2 and Vd are 9.7 μg/mL, 274083 ng min/mL, 80.62 min, and 4.13 L/kg, respectively.
.?C25-140 (10 mg/kg; p.o.) treatment shows that the Cmax, AUC, t1/2 and Vd are 3.4 μg/mL, 124034 ng min/mL, 127.33 min and 13.3 L/kg, respectively.
?C25-140 (10 mg/kg; i.p.) treatment shows that the Cmax, AUC, t1/2 and Vd are 4.2μg/mL, 100000 ng min/mL, 184 min, 25.6 L/kg, respectively.
相关产品:Bioactive Compound Library Plus | Apoptosis Compound Library | Immunology/Inflammation Compound Library | Metabolism/Protease Compound Library | NF-κB Signaling Compound Library | Differentiation Inducing Compound Library | Oxygen Sensing Compound Library | Ubiquitination Compound Library | Pyroptosis Compound Library | Angiogenesis-Related Compound Library | Antidepressant Compound Library | Anti-Prostate Cancer Compound Library | Anti-Pulmonary Fibrosis Compound Library | Heterocyclic Compound Library | Mitochondrial Protection Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Autoimmune Disease Compound Library | Highly Selective Inhibitors Library | Cytokine Inhibitors Library | Resatorvid | TAK-243 | Nutlin-3a | Shikonin | Subasumstat | Idasanutlin | Infliximab | Fisetin | Navtemadlin | ML-792 | Adalimumab | Etanercept | Mezigdomide | N-Formyl-Met-Leu-Phe | PYR-41 | QNZ | Theophylline | MD-224 | 2-D08 | R-7050 | Apremilast | Siremadlin | Cbl-b-IN-1 | RG7112 | Ginkgolic Acid | Milademetan | Indole-3-carbinol | HOIPIN-8 | LS-102
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验use 50 ml cells OD600nm = 0.7 - 1.0 per timepoint / sample add 1.35 ml 37 % Formaldehyde (endconcentration = 1 %), incubate 15 min at 25 °C add 2.5 ml 2.5 M Glycine , incubate 5 min at 25 °C spin down, wash
Replication timing by density transfer
C]- acetate or glucose 0.01% (w/v) [15 N]- ammonium sulfate Amino acids/supplements (as required, added to the same concentration as in normal synthetic medium) --dissolved in "-N" medium and filtered
band and serum with suction. (See attached figure, in preparation)Wash in PBS (or media A) to remove Histopaque (spin 1800 rpm/5 min at 4o C)Remove PBS (or media A) , add 18 ml cold H2 O to lyse RBC, and add 2 ml 10x PBS.Spin 1400 rpm/5min at 4o C.Wash
技术资料暂无技术资料 索取技术资料

















